![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2025
Harbeck, N. 
ORCID: https://orcid.org/0000-0002-9744-7372; Modi, S.; Pusztai, L.; Ohno, S.; Wu, J.; Kim, S.-B.; Yoshida, A.; Fabi, A.; Cao, X.; Joseph, R.; Li, R.; Żurawski, B.; Escrivá-de-Romaní, S. ORCID: https://orcid.org/0000-0001-7816-7589; Meneguetti, R.; Supavavej, A.; Chen, S.-C.; Liu, Z.; Kelly, C.; Curigliano, G. ORCID: https://orcid.org/0000-0003-1781-2518; Symmans, W.F. ORCID: https://orcid.org/0000-0002-1526-184X; Gufran, M.; Ke, J.; Konpa, A.; Herbolsheimer, P. und Boileau, J.-F.
(2025):
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial.
In: Annals of Oncology [Forthcoming]
ORCID: https://orcid.org/0000-0002-9744-7372; Modi, S.; Pusztai, L.; Ohno, S.; Wu, J.; Kim, S.-B.; Yoshida, A.; Fabi, A.; Cao, X.; Joseph, R.; Li, R.; Żurawski, B.; Escrivá-de-Romaní, S. ORCID: https://orcid.org/0000-0001-7816-7589; Meneguetti, R.; Supavavej, A.; Chen, S.-C.; Liu, Z.; Kelly, C.; Curigliano, G. ORCID: https://orcid.org/0000-0003-1781-2518; Symmans, W.F. ORCID: https://orcid.org/0000-0002-1526-184X; Gufran, M.; Ke, J.; Konpa, A.; Herbolsheimer, P. und Boileau, J.-F.
(2025):
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial.
In: Annals of Oncology [Forthcoming]
2020
Cardoso, F.; Paluch-Shimon, S.; Senkus, E.; Curigliano, G.; Aapro, M. S.; Andre, F.; Barrios, C. H.; Bergh, J.; Bhattacharyya, G. S.; Biganzoli, L.; Boyle, F.; Cardoso, M-J; Carey, L. A.; Cortes, J.; El Saghir, N. S.; Elzayat, M.; Eniu, A.; Fallowfield, L.; Francis, P. A.; Gelmon, K.; Gligorov, J.; Haidinger, R.; Harbeck, N.; Hu, X.; Kaufman, B.; Kaur, R.; Kiely, B. E.; Kim, S.-B.; Lin, N. U.; Mertz, S. A.; Neciosup, S.; Offersen, B. V.; Ohno, S.; Pagani, O.; Prat, A.; Penault-Llorca, F.; Rugo, H. S.; Sledge, G. W.; Thomssen, C.; Vorobiof, D. A.; Wiseman, T.; Xu, B.; Norton, L.; Costa, A. und Winer, E. P.
(2020):
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5).
In: Annals of Oncology, Bd. 31, Nr. 12: S. 1623-1649